Genetic Variations of Human CYP2D6 in the Chinese Han Population

• Johansson I , Ingelman-SundbergM. Genetic polymorphism and toxicology – with emphasis on cytochrome P450. Toxicol. Sci.120(1), 1–13 (2011).
   PubMed Web of Science ®Google Scholar
• Nebert DW , RussellDW. Clinical importance of the cytochromes P450. Lancet360(9340), 1155–1162 (2002).
   PubMed Web of Science ®Google Scholar
• Nelson DR . The cytochrome P450 homepage. Hum. Genomics4(1), 59–65 (2009).
   PubMedGoogle Scholar
• Nelson DR , ZeldinDC, HoffmanSM, MaltaisLJ, WainHM, NebertDW. Comparison of cytochrome P450 (CYP) genes from the mouse and human genomes, including nomenclature recommendations for genes, pseudogenes and alternative-splice variants. Pharmacogenetics14(1), 1–18 (2004).
   PubMedGoogle Scholar
• O‘Reilly E , KohlerV, FlitschSL, TurnerNJ. Cytochromes P450 as useful biocatalysts: addressing the limitations. Chem. Commun. (Camb.)47(9), 2490–2501 (2011).
   PubMed Web of Science ®Google Scholar
• Zanger UM , RaimundoS, EichelbaumM. Cytochrome P450 2D6: overview and update on pharmacology, genetics, biochemistry. Naunyn Schmiedebergs Arch. Pharmacol.369(1), 23–37 (2004).
   PubMed Web of Science ®Google Scholar
• Shimada T , YamazakiH, MimuraM, InuiY, GuengerichFP. Inter individual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians. J. Pharmacol. Exp. Ther.270(1), 414–423 (1994).
   PubMed Web of Science ®Google Scholar
• Ingelman-Sundberg M . Pharmacogenetics of cytochrome P450 and its applications in drug therapy: the past, present and future. Trends Pharmacol. Sci.25, 193–200 (2004).
   PubMed Web of Science ®Google Scholar
• Rendic S . Summary of information on human CYP enzymes: human P450 metabolism data. Drug Metab. Rev.34(1–2), 83–448 (2002).
   PubMed Web of Science ®Google Scholar
• Eichelbaum M , SpannbruckerN, SteinckeB, DenglerHJ. Defective N-oxidation of sparteine in man: a new pharmacogenetic defect. Eur. J. Clin. Pharmacol.16(3), 183–187 (1979).
   PubMed Web of Science ®Google Scholar
• Mahgoub A , IdleJR, DringLG, LancasterR, SmithRL. Polymorphic hydroxylation of debrisoquine in man. Lancet2(8038), 584–586 (1977).
   PubMed Web of Science ®Google Scholar
• Aklillu E , PerssonI, BertilssonL, JohanssonI, RodriguesF, Ingelman-SundbergM. Frequent distribution of ultrarapid metabolizers of debrisoquine in an Ethiopian population carrying duplicated and multiduplicated functional CYP2D6 alleles. J. Pharmacol. Exp. Ther.278(1), 441–446 (1996).
   PubMed Web of Science ®Google Scholar
• Gaedigk A , EklundJD, PearceRE et al. Identification and characterization of CYP2D6*56B, an allele associated with the poor metabolizer phenotype. Clin. Pharmacol. Ther. 81(6), 817–820 (2007).
   PubMed Web of Science ®Google Scholar
• Kagimoto M , HeimM, KagimotoK, ZeuginT, MeyerUA. Multiple mutations of the human cytochrome P450IID6 gene (CYP2D6) in poor metabolizers of debrisoquine. Study of the functional significance of individual mutations by expression of chimeric genes. J. Biol. Chem.265(28), 17209–17214 (1990).
   PubMed Web of Science ®Google Scholar
• Marez D , LegrandM, SabbaghN et al. Polymorphism of the cytochrome P450 CYP2D6 gene in a European population: characterization of 48 mutations and 53 alleles, their frequencies and evolution. Pharmacogenetics 7(3), 193–202 (1997).
   PubMedGoogle Scholar
• Raimundo S , FischerJ, EichelbaumM, GrieseEU, SchwabM, ZangerUM. Elucidation of the genetic basis of the common ‘intermediate metabolizer‘ phenotype for drug oxidation by CYP2D6. Pharmacogenetics10(7), 577–581 (2000).
   PubMedGoogle Scholar
• Gough AC , SmithCA, HowellSM, WolfCR, BryantSP, SpurrNK. Localization of the CYP2D gene locus to human chromosome 22q13.1 by polymerase chain reaction, in situ hybridization, and linkage analysis. Genomics15(2), 430–432 (1993).
   PubMed Web of Science ®Google Scholar
• Kimura S , UmenoM, SkodaRC, MeyerUA, GonzalezFJ. The human debrisoquine 4-hydroxylase (CYP2D) locus: sequence and identification of the polymorphic CYP2D6 gene, a related gene, and a pseudogene. Am. J. Hum. Genet.45(6), 889–904 (1989).
   PubMed Web of Science ®Google Scholar
• Ingelman-Sundberg M , SimSC, GomezA, Rodriguez-AntonaC. Influence of cytochrome P450 polymorphisms on drug therapies: pharmacogenetic, pharmacoepigenetic and clinical aspects. Pharmacol. Ther.116(3), 496–526 (2007).
   PubMed Web of Science ®Google Scholar
• Bradford LD . CYP2D6 allele frequency in European Caucasians, Asians, Africans and their descendants. Pharmacogenomics3(2), 229–243 (2002).
   PubMed Web of Science ®Google Scholar
• Sistonen J , SajantilaA, LaoO, CoranderJ, BarbujaniG, FuselliS. CYP2D6 worldwide genetic variation shows high frequency of altered activity variants and no continental structure. Pharmacogenet. Genomics17(2), 93–101 (2007).
   PubMed Web of Science ®Google Scholar
• Yin SJ , NiYB, WangSM, WangX, LouYQ, ZhangGL. Differences in genotype and allele frequency distributions of polymorphic drug metabolizing enzymes CYP2C19 and CYP2D6 in mainland Chinese Mongolian, Hui and Han populations. J. Clin. Pharm. Ther.37(3), 364–369 (2012).
   PubMed Web of Science ®Google Scholar
• Zuo LJ , GuoT, XiaDY, JiaLH. Allele and genotype frequencies of CYP3A4, CYP2C19, and CYP2D6 in Han, Uighur, Hui, and Mongolian Chinese populations. Genet. Test. Mol. Biomarkers16(2), 102–108 (2012).
   PubMed Web of Science ®Google Scholar
• Ji L , PanS, WuJ, Marti-JaunJ, HersbergerM. Genetic polymorphisms of CYP2D6 in Chinese mainland. Chin. Med. J. (Engl.)115(12), 1780–1784 (2002).
   PubMed Web of Science ®Google Scholar
• Li Q , WangR, GuoY, WenS, XuL, WangS. Relationship of CYP2D6 genetic polymorphisms and the pharmacokinetics of tramadol in Chinese volunteers. J. Clin. Pharm. Ther.35(2), 239–247 (2010).
   PubMed Web of Science ®Google Scholar
• Qin S , ShenL, ZhangA et al. Systematic polymorphism analysis of the CYP2D6 gene in four different geographical Han populations in mainland China. Genomics 92(3), 152–158 (2008).
   PubMed Web of Science ®Google Scholar
• Zhou SF . Polymorphism of human cytochrome P450 2D6 and its clinical significance: part I. Clin. Pharmacokinet.48(11), 689–723 (2009).
   PubMed Web of Science ®Google Scholar
• Zhou SF . Polymorphism of human cytochrome P450 2D6 and its clinical significance: part II. Clin. Pharmacokinet.48(11), 761–804 (2009).
   PubMedGoogle Scholar
• Mizutani T . PM frequencies of major CYPs in Asians and Caucasians. Drug Metab. Rev.35(2–3), 99–106 (2003).
   PubMed Web of Science ®Google Scholar
• Neafsey P , GinsbergG, HattisD, SonawaneB. Genetic polymorphism in cytochrome P450 2D6 (CYP2D6), population distribution of CYP2D6 activity. J. Toxicol. Environ. Health B Crit. Rev.12(5–6), 334–361 (2009).
   PubMed Web of Science ®Google Scholar
• Hersberger M , Marti-JaunJ, RentschK, HanselerE. Rapid detection of the CYP2D6*3, CYP2D6*4, and CYP2D6*6 alleles by tetra-primer PCR and of the CYP2D6*5 allele by multiplex long PCR. Clin. Chem.46(8 Pt 1), 1072–1077 (2000).
   PubMed Web of Science ®Google Scholar
• Lovlie R , DalyAK, MolvenA, IdleJR, SteenVM. Ultrarapid metabolizers of debrisoquine: characterization and PCR-based detection of alleles with duplication of the CYP2D6 gene. FEBS Lett.392(1), 30–34 (1996).
   PubMed Web of Science ®Google Scholar
• Adzhubei IA , SchmidtS, PeshkinL et al. A method and server for predicting damaging missense mutations. Nat. Methods 7(4), 248–249 (2010).
   PubMed Web of Science ®Google Scholar
• Chen J , ZhengH, BeiJX et al. Genetic structure of the Han Chinese population revealed by genome-wide SNP variation. Am. J. Hum. Genet. 85(6), 775–785 (2009).
   PubMed Web of Science ®Google Scholar
• Wang B , YangLP, ZhangXZ, HuangSQ, BartlamM, ZhouSF. New insights into the structural characteristics and functional relevance of the human cytochrome P450 2D6 enzyme. Drug Metab. Rev.41(4), 573–643 (2009).
   PubMed Web of Science ®Google Scholar
• Garcia-Barcelo M , ChowLY, ChiuHF et al. Genetic analysis of the CYP2D6 locus in a Hong Kong Chinese population. Clin. Chem. 46(1), 18–23 (2000).
   PubMed Web of Science ®Google Scholar
• Lee SJ , LeeSS, JungHJ et al. Discovery of novel functional variants and extensive evaluation of CYP2D6 genetic polymorphisms in Koreans. Drug Metab. Dispos. 37(7), 1464–1470 (2009).
   PubMed Web of Science ®Google Scholar
• Yue QY , SvenssonJO, SaweJ, BertilssonL. Codeine metabolism in three oriental populations: a pilot study in Chinese, Japanese and Koreans. Pharmacogenetics5(3), 173–177 (1995).
   PubMedGoogle Scholar
• Sachse C , BrockmollerJ, BauerS, RootsI. Cytochrome P450 2D6 variants in a Caucasian population: allele frequencies and phenotypic consequences. Am. J. Hum. Genet.60(2), 284–295 (1997).
   PubMed Web of Science ®Google Scholar
• Scordo MG , CaputiAP, D‘ArrigoC, FavaG, SpinaE. Allele and genotype frequencies of CYP2C9, CYP2C19 and CYP2D6 in an Italian population. Pharmacol. Res.50(2), 195–200 (2004).
   PubMed Web of Science ®Google Scholar
• Gaedigk A , GotschallRR, ForbesNS, SimonSD, KearnsGL, LeederJS. Optimization of cytochrome P4502D6 (CYP2D6) phenotype assignment using a genotyping algorithm based on allele frequency data. Pharmacogenetics9(6), 669–682 (1999).
   PubMedGoogle Scholar
• Llerena A , DoradoP, CalzadillaLR et al. CYP2D6 genotype and debrisoquine hydroxylation phenotype in Cubans and Nicaraguans. Pharmacogenomics J.12(2), 176–183 (2012).
   PubMed Web of Science ®Google Scholar
• Isaza CA , HenaoJ, LópezAM, CacabelosR. Isolation, sequence and genotyping of the drug metabolizer CYP2D6 gene in the Colombian population. Methods Find. Exp. Clin. Pharmacol.22(9), 695–705 (2000).
   PubMedGoogle Scholar
• Dorado P , HerasN, MachínE, HernándezF, TeranE, LlerenaA. CYP2D6 genotype and dextromethorphan hydroxylation phenotype in an Ecuadorian population. Eur. J. Clin. Pharmacol.68(5), 637–644 (2012).
   PubMed Web of Science ®Google Scholar
• Wennerholm A , JohanssonI, MasseleAY et al. Decreased capacity for debrisoquine metabolism among black Tanzanians: analyses of the CYP2D6 genotype and phenotype. Pharmacogenetics 9(6), 707–714 (1999).
   PubMedGoogle Scholar
• Kleywegt GJ , JonesTA. Detection, delineation, measurement and display of cavities in macromolecular structures. Acta Crystallogr. D Biol. Crystallogr.50(Pt 2), 178–185 (1994).
   PubMed Web of Science ®Google Scholar
• Rowland P , BlaneyFE, SmythMG et al. Crystal structure of human cytochrome P450 2D6. J. Biol. Chem. 281(11), 7614–7622 (2006).
   PubMed Web of Science ®Google Scholar

▪ Websites

• CYP2D6 allele nomenclature. www.cypalleles.ki.se/cyp2d6.htm
   Google Scholar
• Protein data bank-2F9Q. www.rcsb.org/pdb/explore/explore.do?structureId=2F9Q
   Google Scholar
• RNA splicing. www.fruitfly.org/seq_tools/splice.html
   Google Scholar
• PolyPhen-2. http://genetics.bwh.harvard.edu/pph2
   Google Scholar
• Arlequin 3.5 program. http://cmpg.unibe.ch/software/arlequin3
   Google Scholar
• Haploview. www.broadinstitute.org/scientific-community/software
   Google Scholar